|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 409/06 | |
| A61K 31/4178 | |||
| A61P 31/10 |
| (11) | Patento numeris | 2964641 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13736983.1 |
| Europos patento paraiškos padavimo data | 2013-06-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/067952 |
| Data | 2013-06-24 |
| (87) | Numeris | WO 2014/136282 |
| Data | 2014-09-12 |
| (30) | Numeris | Data | Šalis |
| 2013046593 | 2013-03-08 | JP |
| (72) |
MASUDA, Takaaki, JP
MIYATA, Yoshiyuki, JP
KANEDA, Hideo, JP
|
| (73) |
Pola Pharma Inc.,
8-9-5, Nishi-gotanda, Shinagawa-ku Tokyo 141-0031,
JP
Nihon Nohyaku Co., Ltd., 19-8, Kyobashi 1-chome Chuo-ku, Tokyo 104-8386, JP |
| (54) | CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT |
| CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT |